Apellis Pharmaceuticals Inc (APLS)
Director Francois Cedric 🟡 adjusted position in 0 shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $3.76 Transaction Date: Feb 03, 2026 | Filing ID: 000081
Director Francois Cedric 🟡 adjusted position in 0 shares (1 derivative) of Apellis Pharmaceuticals, Inc. (APLS) at $3.76 Transaction Date: Feb 03, 2026 | Filing ID: 000081
🔍 Francois Cedric (Director)
Company: Apellis Pharmaceuticals, Inc. (APLS)
Report Date: 2026-02-03
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-02-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 490,837.00 | transaction_form_type: 4
Date: 2026-02-03 | Code: H | nature_of_ownership: Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2) | shares_owned_after: 307,946.00 | Footnotes: F1
Date: 2026-02-03 | Code: H | nature_of_ownership: Indirect Owner (The Cedric Francois Irrevocable Trust of 2023) | shares_owned_after: 472,065.00 | Footnotes: F2
Date: 2026-02-03 | Code: H | nature_of_ownership: Indirect Owner (The Francois Grossi Trust) | shares_owned_after: 300,000.00 | Footnotes: F3
Date: 2026-02-03 | Code: H | nature_of_ownership: Indirect Owner (The Francois-DuBois Educational Trust) | shares_owned_after: 234,411.00 | Footnotes: F4
Date: 2026-02-03 | Code: M | Expires: 2026-02-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5
Footnotes: